Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Naltrexone implant shown to be safe and effective in heroin dependence

Nov. 18, 2009

GSK and Nabi sign option and licensing agreement for NicVAX nicotine vaccine

Nov. 17, 2009

Alkermes reports results from phase III naltrexone trial for opioid dependence

Nov. 17, 2009

Results reported for phase I clinical trial of new slow-release metadoxine

Nov. 9, 2009

Aeolus' AEOL-10150 protects lungs against chlorine gas exposure in animal studies

Nov. 6, 2009

Nabi Biopharmaceuticals starts phase III trial of NicVAX as an aid to stop smoking

Nov. 5, 2009

Nabi Biopharmaceuticals takes part in phase IIb study of NicVAX vaccine

Oct. 29, 2009

Aeolus drug protects gastrointestinal tract in acute radiation syndrome studies

Oct. 26, 2009

Non-selective opioid modulator RDC-5768 reduces behavioral effects of drugs of abuse

Oct. 23, 2009

Novartis reports interim results from phase II trial of Cytos Biotechnology's nicotine vaccine

Oct. 21, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...